Therapeutic Neuroscience Education: Educating Patients About Pain
This class is designed to update attendees on the latest evidence and clinical application of therapeutic neuroscience education for patients in pain. Current best evidence has shown that neuroscience educational strategies utilizing neurobiology and neurophysiology are able to reduce pain, increase function, reduce fear and catastrophization, improve movement and change cognitions and brain activation during pain experiences. Therapeutic neuroscience education changes patient beliefs regarding their pain, thus reducing the threat of pain.
This class will discuss the evolution of therapeutic neuroscience education, why neuroscience education is needed in patient care and, more importantly, the clinical application and implementation of therapeutic neuroscience education for patients with acute, sub-acute and chronic pain. Special features include various metaphors, images, examples and case studies explaining neuroscience to patients in pain. In addition the class will cover clinical issues such as compliance, pacing exercise and activity, incorporation of therapeutic neuroscience education with traditional movement based therapy, billing and insurance reimbursement concerns and delivering therapeutic neuroscience education in busy, time-constrained clinical environments. This class is a must for all professionals dealing with patients in pain.
|8 am||The Patient with Chronic Pain|
|8:30 am||Cognitions and Pain: Fear-Avoidance|
|9 am||Cognitions and Pain: Pain Catastrophization|
|10:15 am||Biomedical Education|
|11 am||Evolution, Evidence and Delivery of Pain Neuroscience Education|
|1 pm||Pain Science Update: Nocicpetive and Peripheral Neurogenic Pain States|
|3:30 pm||Pain Science Update: Central Sensitization and Output Mechanisms in Pain|
|5:15 pm||Screening and Identifying Pain Mechanisms in Clinical Practice|
|8 am||Evaluation and Preparation for Pain Neuroscience Education|
|8:30 am||Clinical Application of Teaching People About Pain|
|10:15 am||Clinical Application of Teaching People About Pain|
|11 am||Pain Neuroscience Education in the Clinic|
|1 pm||Building a Comprehensive Pain Program around Pain Neuroscience Education|
|2:30 pm||Case Study: Chronic Pain|
|3:15 pm||Pre-Emptive Pain Neuroscience Education for Acute and Preoperative Populations|
Physicians, nurses, physical therapists, and other healthcare professionals.
- Discuss the latest evidence for therapeutic neuroscience education.
- Demonstrate the clinical ability to apply therapeutic neuroscience education to clinical practice with the use of at least one metaphor shared in class.
- List at least half of the output systems discussed in class and their response in a chronic pain patient.
- List potential strategies to implement therapeutic neuroscience into clinic practice regarding time, staff, billing and traditional therapeutic treatments.
- Design a treatment plan for a chronic pain patient based on output system dysfunctions with correct pain neurophysiological reasoning behind the treatment with information provided in the course.
Stephen Schmidt, PT, M.Physio, OCS, FAAOMPT
Steve is a physical therapist with over twenty years of experience treating patients with chronic pain and movement dysfunction. His interests in manual therapy, neurology, pain neuroscience and movement impairments led him to pursue a diverse range of training opportunities including two different year-long manual therapy courses, the 6-month program in Proprioceptive Neuromuscular Facilitation (PNF) and a Masters of Physiotherapy (Manipulative Physiotherapy) in Adelaide at the University of South Australia. He currently works at the Kaiser Foundation Rehabilitation Center treating patients with neurological impairments, teaching in the PNF program and serving as adjunct faculty at Samuel Merritt University. He is a Fellow in the American Academy of Orthopaedic Manual Physical Therapists, a board certified specialist in orthopaedic physical therapy and is an instructor with the International Proprioceptive Neuromuscular Facilitation Association (IPNFA). He has taught numerous seminars for the Neuro Orthopaedic Institute (NOI), the International Spine and Pain Institute (ISPI) and is faculty for the ISPI/EIM Pain Specialty Certification Program.
Relevant to the content of this CME activity, Mr. Schmidt indicated he has no financial relationships with commercial interest companies to disclose.
Continuing Education Credit
- MD: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Iowa Medical Society (IMS) through the joint providership of Des Moines University (DMU) and the International Spine and Pain Institute. DMU is accredited by the IMS to provide continuing medical education for physicians. DMU designates this live activity for a maximum of 15.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- DO: Des Moines University (DMU) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. DMU designates this program for a maximum of 15.25 AOA Category 2-A credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.
- Nurse: Des Moines University is Iowa Board of Nursing approved provider #112. This live activity has been reviewed and approved for 15.25 continuing education contact hour(s). No partial credit awarded.
- Other: This live activity is designated for 15.25 AMA PRA Category 1 Credits™.
No commercial interest company provided financial support for this continuing education activity.
Everyone in a position to control the content of this educational activity will disclose to the CME provider and to attendees all relevant financial relationships with any commercial interest. They will also disclose if any pharmaceuticals or medical procedures and devices discussed are investigational or unapproved for use by the U.S. Food and Drug Administration (FDA). Determination of educational content and the selection of speakers is the responsibility of the activity director. Firms providing financial support did not have input in these areas. The information provided at this CME activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The content of each presentation does not necessarily reflect the views of Des Moines University.
- 15.25 AMA PRA Category 1 Credits™
- 15.25 AOA Category 2A
- 15.25 CE Contact Hour(s)
- 15.25 IBON